Pat J Morin
Pat J Morin
Exec. Director, Strategic Alliances, Abramson Cancer Center, University of Pennsylvania
Verified email at upenn.edu
Title
Cited by
Cited by
Year
Identification of c-MYC as a target of the APC pathway
TC He, AB Sparks, C Rago, H Hermeking, L Zawel, LT Da Costa, ...
Science 281 (5382), 1509-1512, 1998
51991998
Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
PJ Morin, AB Sparks, V Korinek, N Barker, H Clevers, B Vogelstein, ...
Science 275 (5307), 1787-1790, 1997
44721997
Constitutive transcriptional activation by a β-catenin-Tcf complex in APC−/− colon carcinoma
V Korinek, N Barker, PJ Morin, D Van Wichen, R De Weger, KW Kinzler, ...
Science 275 (5307), 1784-1787, 1997
36761997
Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer
AB Sparks, PJ Morin, B Vogelstein, KW Kinzler
Cancer research 58 (6), 1130-1134, 1998
12101998
β‐catenin signaling and cancer
PJ Morin
Bioessays 21 (12), 1021-1030, 1999
8661999
Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis
TA Chan, PJ Morin, B Vogelstein, KW Kinzler
Proceedings of the National Academy of Sciences 95 (2), 681-686, 1998
7441998
Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer
CD Hough, CA Sherman-Baust, ES Pizer, FJ Montz, DD Im, ...
Cancer Research 60 (22), 6281-6287, 2000
6192000
Claudin proteins in human cancer: promising new targets for diagnosis and therapy
PJ Morin
Cancer research 65 (21), 9603-9606, 2005
5702005
Apoptosis and APC in colorectal tumorigenesis
PJ Morin, B Vogelstein, KW Kinzler
Proceedings of the National Academy of Sciences 93 (15), 7950-7954, 1996
5681996
A public database for gene expression in human cancers
A Lal, AE Lash, SF Altschul, V Velculescu, L Zhang, RE McLendon, ...
Cancer research 59 (21), 5403-5407, 1999
5411999
The claudin gene family: expression in normal and neoplastic tissues
KJ Hewitt, R Agarwal, PJ Morin
BMC cancer 6 (1), 186, 2006
4902006
MicroRNA expression and identification of putative miRNA targets in ovarian cancer
N Dahiya, CA Sherman-Baust, TL Wang, B Davidson, IM Shih, Y Zhang, ...
PloS one 3 (6), e2436, 2008
4042008
Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells
CA Sherman-Baust, AT Weeraratna, LBA Rangel, ES Pizer, KR Cho, ...
Cancer cell 3 (4), 377-386, 2003
3822003
APC mutations in colorectal tumors with mismatch repair deficiency
J Huang, N Papadopoulos, AJ McKinley, SM Farrington, LJ Curtis, ...
Proceedings of the National Academy of Sciences 93 (17), 9049-9054, 1996
3821996
Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity
R Agarwal, T D'Souza, PJ Morin
Cancer research 65 (16), 7378-7385, 2005
3792005
Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas
LBA Rangel, R Agarwal, T D’Souza, ES Pizer, PL Alň, WD Lancaster, ...
Clinical Cancer Research 9 (7), 2567-2575, 2003
3782003
An anatomy of normal and malignant gene expression
K Boon, EC Osório, SF Greenhut, CF Schaefer, J Shoemaker, K Polyak, ...
Proceedings of the National Academy of Sciences 99 (17), 11287-11292, 2002
3652002
The Yin-Yang of TCF/β-catenin signaling
N Barker, PJ Morin, H Clevers
Advances in cancer research 77, 1-24, 1999
3571999
Coordinately up-regulated genes in ovarian cancer
CD Hough, KR Cho, AB Zonderman, DR Schwartz, PJ Morin
Cancer research 61 (10), 3869-3876, 2001
3342001
The claudins
M Lal-Nag, PJ Morin
Genome biology 10 (8), 1-7, 2009
3162009
The system can't perform the operation now. Try again later.
Articles 1–20